Tissue specific signature of HHV-6 infection in ME/CFS.
Kasimir, Francesca, Toomey, Danny, Liu, Zheng et al. · Frontiers in molecular biosciences · 2022 · DOI
Quick Summary
This study looked for signs of active HHV-6 virus (a common herpesvirus) in brain and spinal cord tissue from ME/CFS patients after death, compared to people without ME/CFS. Using a special detection technique, researchers found markers of active viral infection in the nervous tissue of ME/CFS patients but not in the control group. This suggests that HHV-6 may be reactivating specifically in the brain and nervous system in ME/CFS, rather than in the blood where it's usually tested.
Why It Matters
If HHV-6 is actively replicating specifically in the brain and spinal cord of ME/CFS patients, this could explain why standard blood tests often miss the infection and why neurological symptoms are so prominent in this disease. This finding opens new possibilities for targeted antiviral treatments and could shift how researchers think about the relationship between herpesviruses and ME/CFS pathology.
Observed Findings
Active HHV-6 miRNA (miR-aU14) detected in multiple brain regions of ME/CFS patients using FISH
No detectable HHV-6 miRNA in brain tissue from control subjects
Viral transcripts localized to neuronal tissues including spinal cord in ME/CFS patients
HHV-6 signals absent in commonly tested biological materials (blood/serum) from ME/CFS patients
EBV evidence of concurrent tissue-specific infection also detected in ME/CFS brain tissues
Inferred Conclusions
Active HHV-6 and EBV reactivation occurs in the central nervous system of ME/CFS patients with tissue-specific localization
Standard blood-based testing fails to detect active herpesviral infection due to localization in brain and neural tissues
Tissue-specific rather than systemic viral reactivation may be the key mechanism linking herpesviruses to ME/CFS pathogenesis
Renewed investigation of herpesvirus involvement in ME/CFS is warranted based on this evidence of active CNS infection
Remaining Questions
Does the presence of active HHV-6 in brain tissue cause neurological symptoms, or is it a secondary phenomenon resulting from immune dysregulation?
What This Study Does Not Prove
This study does not prove that HHV-6 causes ME/CFS—it only shows an association in this small group of patients. It cannot determine whether the virus is the primary cause of disease, a consequence of immune dysfunction, or a contributing factor. Additionally, findings from postmortem tissue may not represent what occurs during active disease in living patients.